Pavlo Gilchuk
Pavlo Gilchuk
Unknown affiliation
Verified email at vumc.org
Title
Cited by
Cited by
Year
Potently neutralizing and protective human antibodies against SARS-CoV-2
SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ...
Nature 584 (7821), 443-449, 2020
4392020
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition
AJ Greaney, TN Starr, P Gilchuk, SJ Zost, E Binshtein, AN Loes, SK Hilton, ...
Cell host & microbe 29 (1), 44-57. e9, 2021
3112021
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ...
Nature medicine 27 (4), 717-726, 2021
214*2021
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
SJ Zost, P Gilchuk, RE Chen, JB Case, JX Reidy, A Trivette, RS Nargi, ...
Nature medicine 26 (9), 1422-1427, 2020
1812020
Viral acute lower respiratory infections impair CD8+ T cells through PD-1
JJ Erickson, P Gilchuk, AK Hastings, SJ Tollefson, M Johnson, ...
The Journal of clinical investigation 122 (8), 2967-2982, 2012
1462012
High frequency of shared clonotypes in human B cell receptor repertoires
C Soto, RG Bombardi, A Branchizio, N Kose, P Matta, AM Sevy, ...
Nature 566 (7744), 398-402, 2019
1162019
A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface
S Bangaru, S Lang, M Schotsaert, HA Vanderven, X Zhu, N Kose, ...
Cell 177 (5), 1136-1152. e18, 2019
992019
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
N Suryadevara, S Shrihari, P Gilchuk, LA VanBlargan, E Binshtein, ...
Cell 184 (9), 2316-2331. e15, 2021
612021
Discovering naturally processed antigenic determinants that confer protective T cell immunity
P Gilchuk, CT Spencer, SB Conant, T Hill, JJ Gray, X Niu, M Zheng, ...
The Journal of clinical investigation 123 (5), 1976-1987, 2013
592013
A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein
JJ Mousa, N Kose, P Matta, P Gilchuk, JE Crowe
Nature microbiology 2 (4), 1-8, 2017
582017
A distinct lung-interstitium-resident memory CD8+ T cell subset confers enhanced protection to lower respiratory tract infection
P Gilchuk, TM Hill, C Guy, SR McMaster, KL Boyd, WA Rabacal, P Lu, ...
Cell reports 16 (7), 1800-1809, 2016
522016
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
ES Winkler, P Gilchuk, J Yu, AL Bailey, RE Chen, Z Chong, SJ Zost, ...
Cell 184 (7), 1804-1820. e16, 2021
48*2021
Antibody-dependent enhancement of Ebola virus infection by human antibodies isolated from survivors
NA Kuzmina, P Younan, P Gilchuk, RI Santos, AI Flyak, PA Ilinykh, ...
Cell reports 24 (7), 1802-1815. e5, 2018
472018
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region
AI Flyak, N Kuzmina, CD Murin, C Bryan, E Davidson, P Gilchuk, ...
Nature microbiology 3 (6), 670-677, 2018
462018
Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the ebolavirus glycoprotein
P Gilchuk, N Kuzmina, PA Ilinykh, K Huang, BM Gunn, A Bryan, ...
Immunity 49 (2), 363-374. e10, 2018
432018
A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA
S Bangaru, H Zhang, IM Gilchuk, TG Voss, RP Irving, P Gilchuk, P Matta, ...
Nature communications 9 (1), 1-15, 2018
402018
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail
J Dong, S Zost, A Greaney, TN Starr, AS Dingens, EC Chen, R Chen, ...
BioRxiv, 2021
372021
Poly (propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines
F Qiu, KW Becker, FC Knight, JJ Baljon, S Sevimli, D Shae, P Gilchuk, ...
Biomaterials 182, 82-91, 2018
372018
Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune response
J Yang, OE Hawkins, W Barham, P Gilchuk, M Boothby, GD Ayers, ...
Cancer research 74 (24), 7274-7284, 2014
372014
Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication
AK Hastings, JJ Erickson, JE Schuster, KL Boyd, SJ Tollefson, M Johnson, ...
Journal of virology 89 (8), 4405-4420, 2015
352015
The system can't perform the operation now. Try again later.
Articles 1–20